Photo Quiz: Progressive Skin Fibrosis

摘要

The U.S. Food and Drug Administration (FDA) has issued a black box warning for all gadolinium-based contrast media.9 the FDA recommends screening patients for renal dysfunction before using gadolinium and using alternative imaging methods in patients with acute renal failure, advanced chronic kidney disease (i.e., glomerular filtration rate of less than 30 mL per minute per 1.73 m^sup 2^), or acute renal insufficiency of any severity that is caused by hepatorenal syndrome or that occurs in the postoperative period after a liver transplant.